Neutrophil-mediated delivery of pixantrone-loaded liposomes decorated with poly(sialic acid)–octadecylamine conjugate for lung cancer treatment

References

• Akita S, Hattori N, Masuda T, et al. (2015). MT95‐4, a fully humanized antibody raised against aminopeptidase N, reduces tumor progression in a mouse model. Cancer Sci 106:921–8.
   PubMed Web of Science ®Google Scholar
• Allen TM, Cullis PR. (2004). Drug delivery systems: entering the mainstream. Science 303:1818–22.
   PubMed Web of Science ®Google Scholar
• Allen TM, Cullis PR. (2013). Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev 65:36–48.
   PubMed Web of Science ®Google Scholar
• Arbonés ML, Ord DC, Ley K, et al. (1994). Lymphocyte homing and leukocyte rolling and migration are impaired in l-selectin-deficient mice. Immunity 1:247–60.
   PubMed Web of Science ®Google Scholar
• Bekes EM, Schweighofer B, Kupriyanova TA, et al. (2011). Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation. Am J Pathol 179:1455–70.
   PubMed Web of Science ®Google Scholar
• Benevides L, Da FD, Donate PB, et al. (2015). IL17 promotes mammary tumor progression by changing the behavior of tumor cells and eliciting tumorigenic neutrophils recruitment. Cancer Res 75:3788–99.
   PubMed Web of Science ®Google Scholar
• Brill A, Fuchs TA, Savchenko AS, et al. (2012). Neutrophil extracellular traps promote deep vein thrombosis in mice. J Thromb Haemost 10:136–44.
   PubMed Web of Science ®Google Scholar
• Byrne JD, Betancourt T, Brannon-Peppas L. (2008). Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv Drug Deliv Rev 60:1615–26.
   PubMed Web of Science ®Google Scholar
• Cavalletti E, Crippa L, Mainardi P, et al. (2007). Pixantrone (BBR 2778) has reduced cardiotoxic potential in mice pretreated with doxorubicin: comparative studies against doxorubicin and mitoxantrone. Invest New Drugs 25:187–95.
   PubMed Web of Science ®Google Scholar
• Chang Y, Yang S-T, Liu J-H, et al. (2011). In vitro toxicity evaluation of graphene oxide on A549 cells. Toxicol Lett 200:201–10.
   PubMed Web of Science ®Google Scholar
• Cho K, Wang X, Nie S, Shin DM. (2008). Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 14:1310–6.
   PubMed Web of Science ®Google Scholar
• Coffelt SB, Kersten K, Doornebal CW, et al. (2015). IL17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis. Nature 522:345.
   PubMed Web of Science ®Google Scholar
• Coussens LM, Tinkle CL, Hanahan D, Werb Z. (2000). MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103:481.
   PubMed Web of Science ®Google Scholar
• Coussens LM, Werb Z. (2002). Inflammation and cancer. Nature 420:860.
   PubMed Web of Science ®Google Scholar
• Cullis PR, Hope MJ, Bally MB, et al. (1997). Influence of pH gradients on the transbilayer transport of drugs, lipids, peptides and metal ions into large unilamellar vesicles. Biochim Biophys Acta (BBA)-Rev Biomembr 1331:187–211.
   PubMed Web of Science ®Google Scholar
• Drummond DC, Meyer O, Hong K, et al. (1999). Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol Rev 51:691–744.
   PubMed Web of Science ®Google Scholar
• Duggan ST, Keating GM. (2011). Pegylated liposomal doxorubicin: a review of its use in metastatic breast cancer, ovarian cancer, multiple myeloma and AIDS-related Kaposi's sarcoma. Drugs 71:2531–58.
   PubMed Web of Science ®Google Scholar
• Dumitru CA, Lang S, Brandau S. (2013). Modulation of neutrophil granulocytes in the tumor microenvironment: mechanisms and consequences for tumor progression. Semin Cancer Biol 23:141–8.
   PubMed Web of Science ®Google Scholar
• Dvorak HF. (1986). Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315:1650.
   PubMed Web of Science ®Google Scholar
• Engblom C, Pfirschke C, Zilionis R, et al. (2017). Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neutrophils. Science 358:eaal5081.
   PubMed Web of Science ®Google Scholar
• English D, Andersen BR. (1974). Single-step separation of red blood cells, granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-Hypaque. J Immunol Methods 5:249–52.
   PubMed Web of Science ®Google Scholar
• Eruslanov EB, Bhojnagarwala PS, Quatromoni JG, et al. (2014). Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. J Clin Invest 124:5466.
   PubMed Web of Science ®Google Scholar
• Feng Y, Santoriello C, Mione M, et al. (2006). Live imaging of innate immune cell sensing of transformed cells in zebrafish larvae: parallels between tumor initiation and wound inflammation. PLoS Biol 34:347–73.
   Google Scholar
• Fernandes AI, Gregoriadis G. (1997). Polysialylated asparaginase: preparation, activity and pharmacokinetics. Biochim Biophys Acta (BBA)-Protein Struct Mol Enzymol 1341:26–34.
   PubMed Web of Science ®Google Scholar
• Fernandes AI, Gregoriadis G. (2001). The effect of polysialylation on the immunogenicity and antigenicity of asparaginase: implication in its pharmacokinetics. Int J Pharm 217:215–24.
   PubMed Web of Science ®Google Scholar
• Floyd RA, Chandru HK, He T, Towner R. (2011). Anti-cancer activity of nitrones and observations on mechanism of action. ACAMC 11:373–9.
   Google Scholar
• Fossati G, Ricevuti G, Edwards SW, et al. (1999). Neutrophil infiltration into human gliomas. Acta Neuropathol 98:349.
   PubMed Web of Science ®Google Scholar
• Frangioni JV. (2003). In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol 7:626–34.
   PubMed Web of Science ®Google Scholar
• Fridlender ZG, Sun J, Kim S, et al. (2009). Polarization of tumor-associated neutrophil phenotype by TGF-beta: “N1” versus “N2” TAN. Cancer Cell 16:183.
   PubMed Web of Science ®Google Scholar
• Gerlier D, Thomasset N. (1986). Use of MTT colorimetric assay to measure cell activation. J Immunol Methods 94:57–63.
   PubMed Web of Science ®Google Scholar
• Gregoriadis G, Fernandes A, Mital M, Mccormack B. (2000). Polysialic acids: potential in improving the stability and pharmacokinetics of proteins and other therapeutics. CMLS Cell Mol Life Sci 57:1964–9.
   PubMed Web of Science ®Google Scholar
• Johnson CP, Fujimoto I, Rutishauser U, Leckband DE. (2005). Direct evidence that neural cell adhesion molecule (NCAM) polysialylation increases intermembrane repulsion and abrogates adhesion. J Biol Chem 280:137–45.
   PubMed Web of Science ®Google Scholar
• Kaufmann SH. (2008). Immunology's foundation: the 100-year anniversary of the Nobel Prize to Paul Ehrlich and Elie Metchnikoff. Nat Immunol 9:705–12.
   PubMed Web of Science ®Google Scholar
• Keizer H, Pinedo HM, Schuurhuis GJ, Joenje H. (1990). Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity. Pharmacol Ther 47:219–31.
   PubMed Web of Science ®Google Scholar
• Khan N, Hadi N, Afaq F, et al. (2007). Pomegranate fruit extract inhibits prosurvival pathways in human A549 lung carcinoma cells and tumor growth in athymic nude mice. Carcinogenesis 28:163–73.
   PubMed Web of Science ®Google Scholar
• Kibria G, Hatakeyama H, Sato Y, Harashima H. (2016). Anti-tumor effect via passive anti-angiogenesis of PEGylated liposomes encapsulating doxorubicin in drug resistant tumors. Int J Pharm 509:178–87.
   PubMed Web of Science ®Google Scholar
• Li J, Wang XL, Zhang T, et al. (2015). A review on phospholipids and their main applications in drug delivery systems. Asian J Pharm Sci 10:81–98.
   Web of Science ®Google Scholar
• Luo X, Li J, Guo L, et al. (2013). Preparation of berberine hydrochloride long-circulating liposomes by ionophore A23187-mediated ZnSO4 gradient method. Asian J Pharm Sci 8:261–6.
   Google Scholar
• Ma J, Liu L, Che G, et al. (2010). The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time. BMC Cancer 10:112.
   PubMed Web of Science ®Google Scholar
• Mayadas TN, Cullere X, Lowell CA. (2014). The multifaceted functions of neutrophils. Annu Rev Pathol 9:181–218.
   PubMed Web of Science ®Google Scholar
• Mishalian I, Bayuh R, Levy L, et al. (2013). Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression. Cancer Immunol Immunother 62:1745–56.
   PubMed Web of Science ®Google Scholar
• Moore RJ, Owens DM, Stamp G, et al. (1999). Mice deficient in tumor necrosis factor-|[alpha]| are resistant to skin carcinogenesis. Nat Med 5:828.
   PubMed Web of Science ®Google Scholar
• Nathan C. (2006). Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 6:173.
   PubMed Web of Science ®Google Scholar
• Péan E, Flores B, Hudson I, et al. (2013). The European Medicines Agency review of pixantrone for the treatment of adult patients with multiply relapsed or refractory aggressive non-Hodgkin's B-cell lymphomas: summary of the scientific assessment of the committee for medicinal products for human use. Oncologist 18:625–33.
   PubMed Web of Science ®Google Scholar
• Pettengell R, Coiffier B, Narayanan G, et al. (2012). Pixantrone dimaleate versus other chemotherapeutic agents as a single-agent salvage treatment in patients with relapsed or refractory aggressive non-Hodgkin lymphoma: a phase 3, multicentre, open-label, randomised trial. Lancet Oncol 13:696–706.
   PubMed Web of Science ®Google Scholar
• Powell DR, Huttenlocher A. (2016). Neutrophils in the tumor microenvironment. Trends Immunol 37:41–52.
   PubMed Web of Science ®Google Scholar
• Queen MM, Ryan RE, Holzer RG, et al. (2005). Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression. Cancer Res 65:8896.
   PubMed Web of Science ®Google Scholar
• Raccosta L, Fontana R, Maggioni D, et al. (2013). The oxysterol-CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils. J Exp Med 210:1711.
   PubMed Web of Science ®Google Scholar
• Rotondo R, Barisione G, Mastracci L, et al. (2009). IL-8 induces exocytosis of arginase 1 by neutrophil polymorphonuclears in nonsmall cell lung cancer. Int J Cancer 125:887–93.
   PubMed Web of Science ®Google Scholar
• Rutishauser U. (2008). Polysialic acid in the plasticity of the developing and adult vertebrate nervous system. Nat Rev Neurosci 9:26–35.
   PubMed Web of Science ®Google Scholar
• Samad A, Sultana Y, Aqil M. (2007). Liposomal drug delivery systems: an update review. Curr Drug Deliv 4:297–305.
   PubMedGoogle Scholar
• Sauvage F, Franzè S, Bruneau A, et al. (2016). Formulation and in vitro efficacy of liposomes containing the Hsp90 inhibitor 6BrCaQ in prostate cancer cells. Int J Pharm 499:101–9.
   PubMed Web of Science ®Google Scholar
• She Z, Zhang T, Wang X, et al. (2014). The anticancer efficacy of pixantrone-loaded liposomes decorated with sialic acid–octadecylamine conjugate. Biomaterials 35:5216–25.
   PubMed Web of Science ®Google Scholar
• Shimura S, Yang G, Ebara S, et al. (2000). Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression. Cancer Res 60:5857–61.
   PubMed Web of Science ®Google Scholar
• Summers C, Rankin SM, Condliffe AM, et al. (2010). Neutrophil kinetics in health and disease. Trends Immunol 31:318–24.
   PubMed Web of Science ®Google Scholar
• Sun J, Song Y, Lu M, et al. (2016). Evaluation of the antitumor effect of dexamethasone palmitate and doxorubicin co-loaded liposomes modified with a sialic acid–octadecylamine conjugate. Eur J Pharm Sci 93:177–83.
   PubMed Web of Science ®Google Scholar
• Taurin S, Nehoff H, Greish K. (2012). Anticancer nanomedicine and tumor vascular permeability; where is the missing link? J Control Release 164:265–75.
   PubMed Web of Science ®Google Scholar
• Udagawa T, Wood M. (2010). Tumor–stromal cell interactions and opportunities for therapeutic intervention. Curr Opin Pharmacol 10:369–74.
   PubMed Web of Science ®Google Scholar
• Van Vlasselaer P. 1998. Methods for enriching specific cell-types by density gradient centrifugation. US.
   Google Scholar
• Vij N, Min T, Bodas M, et al. (2016). Neutrophil targeted nano-drug delivery system for chronic obstructive lung diseases. Nanomed: Nanotechnol Biol Med 12:2415–27.
   PubMed Web of Science ®Google Scholar
• Viola A, Sarukhan A, Bronte V, Molon B. (2012). The pros and cons of chemokines in tumor immunology. Trends Immunol 33:496–504.
   PubMed Web of Science ®Google Scholar
• Waage A, Halstensen A, Shalaby R, et al. (1989). Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response. J Exp Med 170:1859–67.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhao Y, Wu Y, et al. (2011). Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles. Biomaterials 32:8281–90.
   PubMed Web of Science ®Google Scholar
• Wislez M, Rabbe N, Marchal J, et al. (2003). Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: role in tumor progression and death. Cancer Res 63:1405.
   PubMed Web of Science ®Google Scholar
• Woods JA, Davis JM, Smith JA, Nieman DC. (1999). Exercise and cellular innate immune function. Med Sci Sports Exerc 31:57–66.
   PubMed Web of Science ®Google Scholar
• Xue J, Zhao Z, Zhang L, et al. (2017). Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence. Nat Nanotechnol 12:692–700.
   PubMed Web of Science ®Google Scholar
• Yang Y, Ma Y, Wang S. (2012). A novel method to load topotecan into liposomes driven by a transmembrane NH 4 EDTA gradient. Eur J Pharm Biopharm 80:332–9.
   PubMed Web of Science ®Google Scholar
• Yang Q, Zhang T, Wang C, et al. (2014). Coencapsulation of epirubicin and metformin in PEGylated liposomes inhibits the recurrence of murine sarcoma S180 existing CD133+ cancer stem-like cells. Eur J Pharm Biopharm 88:737–45.
   PubMed Web of Science ®Google Scholar
• Zhang T, Zhou S, Hu L, et al. (2016). Polysialic acid-modifying liposomes for efficient delivery of epirubicin, in-vitro characterization and in-vivo evaluation. Int J Pharm 515:449–59.
   PubMed Web of Science ®Google Scholar
• Zhou S, Zhang T, Peng B, et al. (2017). Targeted delivery of epirubicin to tumor-associated macrophages by sialic acid-cholesterol conjugate modified liposomes with improved antitumor activity. Int J Pharm 523:203–16.
   PubMed Web of Science ®Google Scholar